ANSBERT GADICKE
CIK 1134655 · last filed 2025-11-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$455.51M
Companies
22
Total Filings
84
Lifetime Open-Market Net
-$60.70M
Filer Profile
Reported Address
399 BOYLSTON STREETSUITE 1100
BOSTON, MA 02116
Related Filers
LUKE EVNIN — 164 joint filings, latest 2026-08-31
MICHAEL STEINMETZ — 102 joint filings, latest 2013-02-07
NICHOLAS GALAKATOS — 80 joint filings, latest 2013-02-07
KURT WHEELER — 68 joint filings, latest 2013-02-07
DENNIS HENNER — 56 joint filings, latest 2012-07-10
MPM BioImpact LLC — 46 joint filings, latest 2025-12-04
Oncology Impact Fund (Cayman) Management L.P. — 46 joint filings, latest 2025-12-04
UBS Oncology Impact Fund L.P. — 46 joint filings, latest 2025-12-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HOWL | 10%+ Owner | 6,147,610 | $0.96 | $5.91M | $21.57M | 3 | 2025-11-03 |
| TRDA | 10%+ Owner | 4,402,849 | $6.19 | $27.25M | -$9.17M | 1 | 2024-12-12 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | Director | 374,171 | $1.48 | $553.8K | $20.47M | 2 | 2023-05-24 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Director | 726,303 | $9.81 | $7.13M | $0 | 5 | 2022-08-01 |
| CGEM | Director | 7,892,819 | $14.76 | $116.46M | -$2.55M | 11 | 2022-06-23 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | 5,393,967 | $10.15 | $54.75M | -$32.18M | 6 | 2021-09-30 |
| Repare Therapeutics Inc. (RPTX) Delisted | 10%+ Owner | 3,940,497 | $2.65 | $10.44M | -$35.72M | 14 | 2021-07-13 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | 10%+ Owner | 656,146 | $23.01 | $15.10M | -$46.51M | 3 | 2021-05-04 |
| Oncorus, Inc. (ONCR) Delisted | 10%+ Owner | 2,225,801 | $0.12 | $268.3K | $4.88M | 1 | 2020-10-08 |
| Radius Health, Inc. (RDUS) Delisted | Director | 3,887,502 | $30.00 | $116.63M | $0 | 7 | 2017-02-22 |
| CHIASMA, INC (CHMA) Delisted | Director | 2,498,597 | $3.76 | $9.39M | $0 | 2 | 2016-06-13 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | 10%+ Owner | 37,117 | — | — | -$538.5K | 1 | 2014-03-11 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 2,488,329 | $1.47 | $3.66M | $0 | 1 | 2013-06-06 |
| PCRX | 10%+ Owner | 2,790,479 | $25.12 | $70.11M | -$14.36M | 3 | 2013-03-13 |
| VSTM | Director | 161,111 | $7.79 | $1.25M | $1.00M | 2 | 2012-03-08 |
| Pharmasset Inc (VRUS) Delisted | Director | 7 | — | — | $1.82M | 5 | 2008-06-18 |
| Altimmune, Inc. (PIP) Delisted | 10%+ Owner | 348,944 | — | — | $6.74M | 3 | 2007-10-29 |
| MEMY | 10%+ Owner | 14,238,773 | $16.47 | $234.53M | $0 | 2 | 2007-10-02 |
| Pernix Sleep, Inc. (SOMX) Delisted | 10%+ Owner | 429,168 | — | — | -$10.32M | 2 | 2007-05-03 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | 10%+ Owner | 6,858,211 | — | — | $34.18M | 1 | 2007-05-01 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | 3,847,080 | $1.95 | $7.50M | $0 | 1 | 2007-02-15 | |
| COTHERIX INC (CTRX) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2007-01-10 |
Recent Filings · Page 3 of 9
84 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-07-13 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −62,079 | -$2.08M | EDGAR |
| 2021-06-30 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −19,200 | -$653.9K | EDGAR |
| 2021-06-28 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −28,688 | -$961.5K | EDGAR |
| 2021-06-23 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −42,798 | -$1.47M | EDGAR |
| 2021-06-21 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −41,518 | -$1.40M | EDGAR |
| 2021-06-16 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −6,227 | -$207.1K | EDGAR |
| 2021-06-10 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −61,430 | -$2.09M | EDGAR |
| 2021-06-07 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −58,149 | -$1.86M | EDGAR |
| 2021-06-02 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −38,098 | -$1.24M | EDGAR |
| 2021-05-27 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −38,559 | -$1.27M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.